On Tuesday, Novo Nordisk filed a lawsuit against American rival Eli Lilly, the maker of GLP-1 drugs Mounjaro and Zepbound, accusing it of false advertising
Future Trends in ELISA Sensitivity The future of ELISA is focused on increasing sensitivity, reducing assay time, and integrating modern technologies for improved analytical performance
Also, avoid low-sodium salt substitutes, as these are often made of potassium chloride
This work was supported by grants from the Hainan Province Clinical Medical Center (QWYH202175), the Scientific Research Project of Hainan Health Committee (21A200115), the Research and Cultivation Fund of Hainan Medical University (HYPY2020015), the Specific Research Fund of The Innovation Platform for Academicians of Hainan Province (YSPTZX202311), the Natural Science Foundation of Hainan Province (820RC771), and the Key R&D Projects of Hainan Province (ZDYF2022SHFZ074)
Both medications have very similar side effect profiles
My glucose, HbA1c, and insulin were all excellent